期刊文献+

平肝熄风胶囊治疗风火上扰型脑梗死急性期100例 被引量:7

Pinggan Xifeng Capsule for Treatment of 100 Cases of Acute Cerebral Infarction with Wind-fire Ascending Syndrome
下载PDF
导出
摘要 目的观察平肝熄风胶囊治疗风火上扰型脑梗死急性期的疗效,并探讨其作用机制。方法将200例风火上扰型脑梗死病人随机分为平肝熄风胶囊治疗组(治疗组)和淀粉胶囊治疗组(对照组),观察两组治疗前后主要症状、体征及高敏C反应蛋白(hs-CRP)、纤维蛋白原(FIB)、D-二聚体的变化。结果治疗组临床总有效率为90%,对照组总有效率为63%,两组比较差异有统计学意义(P<0.01);治疗组治疗后hs-CRP、FIB及D-二聚体明显降低(P<0.01),与对照组治疗后比较差异有统计学意义(P<0.05)。结论平肝熄风胶囊治疗风火上扰型脑梗死急性期安全、有效。 Objective To observe the effect of Pinggan Xifeng capsule(PXC) on acute cerebral infarction(ACI) with wind-fire ascending syndrome.Methods Two hundreds patients with ACI and wind-fire ascending syndrome were divided into two groups:Treatment group treated with PXC and control group treated with starch capsule.The symptoms,signs,high sensitive C-reactive protein(hs-CRP),fibrinogen(FIB)and D-dimer were observed after treatment.Results The total clinical effective rate was 90% in treatment group,which was superior to control group(63%,P0.01).Compared with control group,the levels of hs-CRP,FIB and D-dimer were reduced in treatment group(P0.01).Conclusion PXC was effective and safe in treating acute cerebral infarction patients with wind-fire ascending syndrome.
出处 《中西医结合心脑血管病杂志》 2011年第2期164-166,共3页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
基金 山东省潍坊市科委鉴定基金课题(No.2009194)
关键词 脑梗死 平肝熄风胶囊 风火上扰型 cerebral infarction Pinggan Xifeng capsule wind-fire ascending syndrome
  • 相关文献

参考文献6

二级参考文献8

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33058
  • 2Kanagawa Y,Shigekiyo T,Aihara K,et al.Molecular mechanism of type I congenital heparin cofactor (HC) II deficiency caused by a missense mutation at reactive P2 site:HC II Tokushima.Thromb Haemost,2001,85(1):101~107.
  • 3Wada H,Mori Y,Okabayashi K,et al.High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.Am J Hematol,2003,72(1):1~7.
  • 4Ono N,Koyama T,Suehiro A,et al.Clinical significance of new coagulation and fibrinolytic markers in ischemic stroke patients[].Stroke.1991
  • 5Tohgi H,Tadahashi H,Chiba K,et al.Coagulation-fibrinolysis system in poststroke patients receiving antiplatelet medication[].Stroke.1993
  • 6Tohgi H,Kawashima M,Tamula K,et al.Coagulation-fibrnolysis abnomalities in acute and chronic phases of cerebral thrombosis and embolism[].Stroke.1990
  • 7Wilhelmsen L,Svardsudd K,Korsan-Bengtsen K,et al.Fibrinogen as a risk factor for stroke and myocardial infarction[].The New England Journal of Medicine.1984
  • 8Bauer KA,Weiss LM,Sparrow D,et al.Aging-associated changes in indices of thrombin generation and protein C in humans[].The Journal of Clinical Investigation.1987

共引文献46535

同被引文献120

引证文献7

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部